Shanghai Allist Pharmaceuticals (688578) Q2 2025 earnings summary

Executive summary

• Announced a mid-year cash dividend of RMB 0.40 per share (pre-tax) for the first half of 2025, totaling RMB 180 million based on 450 million shares.

• Dividend plan was authorized by the 2024 annual shareholders' meeting and approved by the board on May 14, 2025.

Capital allocation and financing

• Dividend will be distributed to all shareholders registered by the close of trading on September 9, 2025.

• Cash dividend payment date is September 10, 2025.

• Major shareholders will receive dividends directly from the company; others via the clearing system.

Significant events and developments

• No differentiated dividend policy; all shares receive the same per-share dividend.

• Dividend distribution follows approval and authorization procedures as per company governance.